期刊名称:MEDICAL LETTER ON DRUGS AND THERAPEUTICS
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Medical Letter on Drugs and Therapeutics
The Medical Letter is a nonprofit organization founded in 1958 by Arthur Kallet, the co-founder and former director of Consumers Union, and Dr. Harold Aaron, a former medical advisor to Consumers Union.
|
Its newsletters, The Medical Letter on Drugs and Therapeutics and Treatment Guidelines from The Medical Letter, publish critical appraisals of new drugs and comparative reviews of older drugs. The editorial process used for both publications relies on a consensus of experts to develop prescribing recommendations that are completely independent of the pharmaceutical industry. The Medical Letter and Treatment Guidelines are, therefore, crucial resources for members of the health care community to consult when confronted by the advertisements and sales representatives of the industry. |
 |
Instructions to Authors
An expert consultant or one of our editors prepares a preliminary report on the drug (for The Medical Letter) or drugs for particular indications (for Treatment Guidelines) in terms of their effectiveness, adverse effects and possible alternatives. Both published and available unpublished studies are carefully examined, paying special attention to the results of controlled clinical trials.
The preliminary draft is edited and sent to every member of the Advisory Board of The Medical Letter, to 10 to 20 other investigators who have special clinical and experimental experience with the drug, type of drug or disease under review, to appropriate representatives of the pharmaceutical companies making the drugs, and sometimes to companies that make competitive drugs as well.
Many criticisms, suggestions and questions come in from the reviewers in letters, faxes, e-mail and telephone calls. Further extended communication as needed is followed by final checking and editing to make the appraisal not only accurate, but also easy to read.
Editorial Board
| EDITOR |
Mark Abramowicz, M.D. |
 |
 |
| DEPUTY EDITOR |
Gianna Zuccotti, M.D., M.P.H. Weill Medical College of Cornell University |
   |
 |
| CONSULTING EDITOR |
Martin A. Rizack, M.D. Ph.D. The Rockefeller University |
   |
 |
| CONTRIBUTING EDITORS |
Philip D. Hansten, Pharm. D. University of Washington |
   |
 |
   |
Neal H. Steigbigel, M.D. New York University School of Medicine |
   |
 |
| ASSOCIATE EDITORS |
Donna Goodstein |
   |
Amy Faucard |
   |
 |
| MANAGING EDITOR |
Susie Wong |
   |
 |
| ADVISORY BOARD |
Jules Hirsch, M.D. The Rockefeller University |
   |
 |
   |
James D. Kenney, M.D. Yale University School of Medicine |
   |
 |
   |
Gerald L. Mandell, M.D. University of Virginia School of Medicine |
   |
 |
   |
Hans Meinertz, M.D. University Hospital, Copenhagen |
   |
 |
   |
Dan M. Roden, M.D. Vanderbilt School of Medicine |
   |
 |
   |
F. Estelle R. Simons, M.D. University of Manitoba |
   |
 |
EDITORIAL FELLOWS
|
Elizabeth Stephens, M.D. Oregon Health Sciences University School of Medicine |
   |
 |
   |
Arthur M.F. Yee, M.D., Ph.D. Cornell University Medical Center |
|